MTOR and breast cancer: Taken together, Tan I demonstrated potential to induce anti-proliferative activity and cell cycle arrest against breast cancer MCF-7 and MDA-MB-453 cells, which may be associated with its inhibitory effects on the signaling pathways of PI3K/Akt/mTOR in the breast cancer cells.